SERES THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.02 USD | -0.97% |
|
-12.07% | -27.14% |
| 09/05 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
| 09/05 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SERES THERAPEUTICS, INC. | Bio Therapeutic Drugs | -0.97% | -12.07% | -27.14% | -81.39% | -77.83% | 154M |  | |  |
- Stock Market
- Equities
- MCRB Stock
- Charts Seres Therapeutics, Inc.
- Relative Strength Chart
